Literature DB >> 17292733

Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice.

Shinsuke Yoshizumi1, Susumu Suzuki, Masashi Hirai, Yoshinori Hinokio, Tetsuya Yamada, Takahiro Yamada, Uiko Tsunoda, Hiroyuki Aburatani, Kazunori Yamaguchi, Taeko Miyagi, Yoshitomo Oka.   

Abstract

Membrane microdomains rich in gangliosides are recognized as being critical for proper compartmentalization of insulin signaling. Plasma membrane-associated sialidase, NEU3, is a key enzyme for ganglioside hydrolysis. We previously reported that mice overexpressing NEU3 mainly in muscles developed severe insulin-resistant diabetes. To examine the possible contributions of NEU3 to in vivo insulin sensitivity and glucose tolerance, NEU3 was expressed by using adenoviral vectors in the livers of C57BL/6 mice on standard and high-fat diets, and insulin-resistant KKAy mice on standard diets. Hepatic NEU3 overexpression paradoxically improved glucose tolerance and insulin sensitivity in the C57BL/6 mice fed standard diets, and glucose tolerance in the C57BL/6 mice fed high-fat diets and in KKAy mice. Hepatic NEU3 overexpression increased hepatic glycogen deposition and triglyceride accumulation, and enhanced the hepatic peroxisome proliferator-activated receptor gamma and fetuin expression in the C57BL/6 mice on standard and high-fat diets, and in KKAy mice. Thin-layer chromatographic analysis demonstrated increased levels of GM1 and markedly reduced GM3 in the livers of mice with hepatic NEU3 overexpression (NEU3 mice). Basal and insulin-stimulated tyrosine phosphorylations of insulin receptor substrate 1 were significantly increased, but tyrosine phosphorylations of the insulin receptor and insulin receptor substrate 2 in the NEU3 liver were unchanged. Insulin-stimulated tyrosine phosphorylations of the insulin receptor were increased in adipose tissues of NEU3 mice. These results suggest that hepatic NEU3 overexpression improves insulin sensitivity and glucose tolerance through modification of ganglioside composition and peroxisome proliferator-activated receptor gamma signaling. Our findings also provide further evidence that NEU3 is an important regulator of insulin sensitivity and glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292733     DOI: 10.1016/j.metabol.2006.10.027

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

1.  Human airway epithelia express catalytically active NEU3 sialidase.

Authors:  Erik P Lillehoj; Sang Won Hyun; Chiguang Feng; Lei Zhang; Anguo Liu; Wei Guang; Chinh Nguyen; Wenji Sun; Irina G Luzina; Tonya J Webb; Sergei P Atamas; Antonino Passaniti; William S Twaddell; Adam C Puché; Lai-Xi Wang; Alan S Cross; Simeon E Goldblum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-03-21       Impact factor: 5.464

2.  Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.

Authors:  Cen Xie; Tomoki Yagai; Yuhong Luo; Xianyi Liang; Tao Chen; Qiong Wang; Dongxue Sun; Jie Zhao; Sadeesh K Ramakrishnan; Lulu Sun; Chunmei Jiang; Xiang Xue; Yuan Tian; Kristopher W Krausz; Andrew D Patterson; Yatrik M Shah; Yue Wu; Changtao Jiang; Frank J Gonzalez
Journal:  Nat Med       Date:  2017-10-09       Impact factor: 53.440

Review 3.  Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance.

Authors:  C Lipina; H S Hundal
Journal:  Diabetologia       Date:  2011-04-06       Impact factor: 10.122

4.  Genome-Wide Association Study of Meat Quality Traits in Nellore Cattle.

Authors:  Ana F B Magalhães; Gregório M F de Camargo; Gerardo A Fernandes; Daniel G M Gordo; Rafael L Tonussi; Raphael B Costa; Rafael Espigolan; Rafael M de O Silva; Tiago Bresolin; Willian B F de Andrade; Luciana Takada; Fabieli L B Feitosa; Fernando Baldi; Roberto Carvalheiro; Luis A L Chardulo; Lucia G de Albuquerque
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

5.  Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes.

Authors:  Gitanjali Dharmadhikari; Katharina Stolz; Michael Hauke; Noel G Morgan; Ajit Varki; Eelco de Koning; Sørge Kelm; Kathrin Maedler
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

6.  Implications for the mammalian sialidases in the physiopathology of skeletal muscle.

Authors:  Alessandro Fanzani; Alessandra Zanola; Fiorella Faggi; Nadia Papini; Bruno Venerando; Guido Tettamanti; Maurilio Sampaolesi; Eugenio Monti
Journal:  Skelet Muscle       Date:  2012-11-01       Impact factor: 4.912

7.  Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet.

Authors:  J T Brozinick; E Hawkins; H Hoang Bui; M-S Kuo; B Tan; P Kievit; K Grove
Journal:  Int J Obes (Lond)       Date:  2012-12-04       Impact factor: 5.095

8.  How Do Gangliosides Regulate RTKs Signaling?

Authors:  Sylvain Julien; Marie Bobowski; Agata Steenackers; Xuefen Le Bourhis; Philippe Delannoy
Journal:  Cells       Date:  2013-12-06       Impact factor: 6.600

9.  The mechanisms of delayed onset type adverse reactions to oseltamivir.

Authors:  Rokuro Hama
Journal:  Infect Dis (Lond)       Date:  2016-06-02

Review 10.  Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.

Authors:  Fiona Haxho; Ronald J Neufeld; Myron R Szewczuk
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.